Access Resources
4811 - 4820 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disordersJournal Name: Quality of Life ResearchPublisher: Springer Science and Business Media LLCVol: 28Issue #: 7Start Page: 1893End Page: 1901Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11136-019-02164-2Best OA location URL: https://europepmc.org/articles/pmc7071345?pdf=renderCitation Count: 18
-
RESTRICTEDTitle: Early Dyskinesias in Parkinson’s Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.00273Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2019.00273/pdfCitation Count: 9
-
RESTRICTEDTitle: Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 5Start Page: 704End Page: 714Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25450Best OA location URL: https://doi.org/10.1002/ana.25450Citation Count: 101
-
RESTRICTEDTitle: A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 15Start Page: 7419End Page: 7424Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1821778116Best OA location URL: https://www.pnas.org/content/pnas/116/15/7419.full.pdfCitation Count: 51
-
RESTRICTEDTitle: Targeting of the unfolded protein response (UPR) as therapy for Parkinson's diseaseJournal Name: Biology of the CellPublisher: WileyVol: 111Issue #: 6Start Page: 161End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/boc.201800068Citation Count: 36
-
RESTRICTEDTitle: A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologiesJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 5Start Page: 657End Page: 663Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27671Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/636637/2/Espay_et_al-2019-Movement_Disorders.pdfCitation Count: 207
-
RESTRICTEDTitle: The Parkinson's disease e‐diary: Developing a clinical and research tool for the digital ageJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 5Start Page: 676End Page: 681Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27673Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114172Citation Count: 43
-
RESTRICTEDTitle: Discovery of Volatile Biomarkers of Parkinson’s Disease from SebumJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 5Issue #: 4Start Page: 599End Page: 606Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acscentsci.8b00879Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acscentsci.8b00879Citation Count: 101
-
RESTRICTEDTitle: Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 12Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/cts.12619Best OA location URL: https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12619Citation Count: 15
-
RESTRICTEDTitle: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicityJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 939End Page: 960Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-01993-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-01993-2.pdfCitation Count: 61